Scholarly Index
Richard D. Klausner
Lyell Immunopharma (United States); 51,988 total citations; 270 total publications; best world rank #128
Lyell Immunopharma (United States)
51,988Total citations
270Total publications
127H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 176 | US 115 | 99.62 |
| RNA modifications and cancer | Lifetime | 285 | US 158 | 99.32 |
| Lipid Membrane Structure and Behavior | Lifetime | 152 | US 83 | 99.14 |
| Glycosylation and Glycoproteins Research | Lifetime | 304 | US 150 | 98.85 |
| Cellular transport and secretion | Lifetime | 128 | US 66 | 99.19 |
| RNA Research and Splicing | Lifetime | 471 | US 292 | 98.62 |
| RNA and protein synthesis mechanisms | Lifetime | 577 | US 348 | 98.81 |
| T-cell and B-cell Immunology | Lifetime | 586 | US 306 | 98.91 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 283 | US 149 | 97.95 |
| Calcium signaling and nucleotide metabolism | Lifetime | 394 | US 136 | 92.46 |